We generated murine 4T1 breast cancer cells that stably overexpressed LOX and LOXL2, respectively, using a lentiviral delivery system to test whether lysyl oxidases indeed conferred a chemoprotective modification of the tumor ECM (Fig. 2a). Here, LOXL2 is linked to breast cancer.